These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 1712812

  • 1. HLA-binding regions of HIV-1 proteins. II. A systematic study of viral proteins.
    Choppin J, Martinon F, Connan F, Pauchard M, Gomard E, Levy JP.
    J Immunol; 1991 Jul 15; 147(2):575-83. PubMed ID: 1712812
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1.
    Ikeda-Moore Y, Tomiyama H, Miwa K, Oka S, Iwamoto A, Kaneko Y, Takiguchi M.
    J Immunol; 1997 Dec 15; 159(12):6242-52. PubMed ID: 9550428
    [Abstract] [Full Text] [Related]

  • 7. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
    van Baalen CA, Klein MR, Geretti AM, Keet RI, Miedema F, van Els CA, Osterhaus AD.
    AIDS; 1993 Jun 15; 7(6):781-6. PubMed ID: 7689847
    [Abstract] [Full Text] [Related]

  • 8. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T, Harrer E, Barbosa P, Kaufmann F, Wagner R, Brüggemann S, Kalden JR, Feinberg M, Johnson RP, Buchbinder S, Walker BD.
    J Immunol; 1998 Nov 01; 161(9):4875-81. PubMed ID: 9794421
    [Abstract] [Full Text] [Related]

  • 9. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
    Jansen CA, Kostense S, Vandenberghe K, Nanlohy NM, De Cuyper IM, Piriou E, Manting EH, Miedema F, van Baarle D.
    Eur J Immunol; 2005 Jan 01; 35(1):150-8. PubMed ID: 15593302
    [Abstract] [Full Text] [Related]

  • 10. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
    Bond KB, Sriwanthana B, Hodge TW, De Groot AS, Mastro TD, Young NL, Promadej N, Altman JD, Limpakarnjanarat K, McNicholl JM.
    AIDS Res Hum Retroviruses; 2001 May 20; 17(8):703-17. PubMed ID: 11429111
    [Abstract] [Full Text] [Related]

  • 11. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA, Oka S, Takiguchi M.
    Tissue Antigens; 2005 Oct 20; 66(4):305-13. PubMed ID: 16185326
    [Abstract] [Full Text] [Related]

  • 12. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
    Hadida F, Parrot A, Kieny MP, Sadat-Sowti B, Mayaud C, Debre P, Autran B.
    J Clin Invest; 1992 Jan 20; 89(1):53-60. PubMed ID: 1370302
    [Abstract] [Full Text] [Related]

  • 13. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef.
    Hadida F, Haas G, Zimmermann N, Hosmalin A, Spohn R, Samri A, Jung G, Debre P, Autran B.
    J Immunol; 1995 Apr 15; 154(8):4174-86. PubMed ID: 7535824
    [Abstract] [Full Text] [Related]

  • 14. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM, Lawrence J, Schapiro JM, Altman JD, Winters MA, Crompton M, Loi M, Kundu SK, Davis MM, Merigan TC.
    J Immunol; 1999 Feb 01; 162(3):1780-8. PubMed ID: 9973442
    [Abstract] [Full Text] [Related]

  • 15. Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic mice.
    Schönbach C, Nokihara K, Bangham CR, Kariyone A, Karaki S, Shida H, Takatsu K, Egawa K, Wiesmüller KH, Takiguchi M.
    Virology; 1996 Dec 01; 226(1):102-12. PubMed ID: 8941327
    [Abstract] [Full Text] [Related]

  • 16. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar 01; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 17. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase.
    van der Burg SH, Klein MR, van de Velde CJ, Kast WM, Miedema F, Melief CJ.
    AIDS; 1995 Feb 01; 9(2):121-7. PubMed ID: 7536421
    [Abstract] [Full Text] [Related]

  • 18. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope.
    Nietfield W, Bauer M, Fevrier M, Maier R, Holzwarth B, Frank R, Maier B, Riviere Y, Meyerhans A.
    J Immunol; 1995 Mar 01; 154(5):2189-97. PubMed ID: 7868892
    [Abstract] [Full Text] [Related]

  • 19. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H, Miwa K, Shiga H, Moore YI, Oka S, Iwamoto A, Kaneko Y, Takiguchi M.
    J Immunol; 1997 May 15; 158(10):5026-34. PubMed ID: 9144523
    [Abstract] [Full Text] [Related]

  • 20. Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides.
    Sewell AK, Harcourt GC, Goulder PJ, Price DA, Phillips RE.
    Eur J Immunol; 1997 Sep 15; 27(9):2323-9. PubMed ID: 9341776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.